Alternus Energy shows turn to positive EBITDA and strong revenue growth in financial results for the year ended December 31, 2020Proactive Investors • 03/10/21
Alternus Energy harnesses the power of the sun to play a leading role in the green energy driveProactive Investors • 03/03/21
Altimmune' (ALT) CEO Vipin Garg on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/25/21
Altimmune starts enrolling early-stage trial for its nasal spray COVID-19 vaccine candidateMarket Watch • 02/25/21
Altimmune Commences Enrollment in Phase 1 Clinical Trial of AdCOVID™ -- a Needle-Free, Single-Dose Intranasal COVID-19 Vaccine CandidateGlobeNewsWire • 02/25/21
Altimmune Begins Multinational Phase 2 Clinical Trial of HepTcellTM, a Novel Immunotherapeutic for the Treatment of Chronic Hepatitis BGlobeNewsWire • 12/30/20
Now Could Be the Perfect Time to Buy This Under-the-Radar COVID Vaccine StockThe Motley Fool • 12/30/20
Altimmune: AdCOVID's Potential To Prevent Transmission May Be Key To Ending The PandemicSeeking Alpha • 12/29/20
Clinical hold on COVID-19 vaccine candidate sends Altimmune down 10% (ALT)Business Insider • 12/24/20
Altimmune Provides an Update on its Investigational New Drug Application for a Phase 1 AdCOVID™ Clinical TrialGlobeNewsWire • 12/23/20